London · Delayed Price · Currency is GBP · Price in GBX LungLife AI Statistics
Total Valuation
LungLife AI has a market cap or net worth of GBP 1.27 million. The enterprise value is -633,048.
| Market Cap | 1.27M |
| Enterprise Value | -633,048 |
Important Dates
The last earnings date was Thursday, May 22, 2025.
| Earnings Date | May 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LungLife AI has 30.66 million shares outstanding. The number of shares has increased by 5.67% in one year.
| Current Share Class | 30.66M |
| Shares Outstanding | 30.66M |
| Shares Change (YoY) | +5.67% |
| Shares Change (QoQ) | +11.33% |
| Owned by Insiders (%) | 26.15% |
| Owned by Institutions (%) | 42.94% |
| Float | 10.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 55.45 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.18 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.18 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.83 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -140.09 |
Financial Efficiency
Return on equity (ROE) is -48.59% and return on invested capital (ROIC) is -30.30%.
| Return on Equity (ROE) | -48.59% |
| Return on Assets (ROA) | -27.28% |
| Return on Invested Capital (ROIC) | -30.30% |
| Return on Capital Employed (ROCE) | -57.70% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2,868 |
| Profits Per Employee | -441,825 |
| Employee Count | 15 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.16% in the last 52 weeks. The beta is 0.37, so LungLife AI's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -78.16% |
| 50-Day Moving Average | 2.16 |
| 200-Day Moving Average | 6.99 |
| Relative Strength Index (RSI) | 72.73 |
| Average Volume (20 Days) | 504,084 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LungLife AI had revenue of GBP 22,947 and -3.53 million in losses. Loss per share was -0.13.
| Revenue | 22,947 |
| Gross Profit | 22,947 |
| Operating Income | -3.66M |
| Pretax Income | -3.53M |
| Net Income | -3.53M |
| EBITDA | -3.45M |
| EBIT | -3.66M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 2.07 million in cash and 166,958 in debt, with a net cash position of 1.91 million or 0.06 per share.
| Cash & Cash Equivalents | 2.07M |
| Total Debt | 166,958 |
| Net Cash | 1.91M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 6.28M |
| Book Value Per Share | 0.22 |
| Working Capital | 1.52M |
Cash Flow
In the last 12 months, operating cash flow was -3.37 million and capital expenditures -60,928, giving a free cash flow of -3.43 million.
| Operating Cash Flow | -3.37M |
| Capital Expenditures | -60,928 |
| Free Cash Flow | -3.43M |
| FCF Per Share | -0.11 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -15,941.26% |
| Pretax Margin | -15,389.54% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LungLife AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.67% |
| Shareholder Yield | n/a |
| Earnings Yield | -277.81% |
| FCF Yield | -269.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LungLife AI has an Altman Z-Score of -5.25. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.25 |
| Piotroski F-Score | n/a |